Page last updated: 2024-11-02

oxidopamine and Epileptiform Neuralgia

oxidopamine has been researched along with Epileptiform Neuralgia in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dieb, W1
Ouachikh, O1
Durif, F1
Hafidi, A1
Abdallah, K1
Monconduit, L1
Artola, A1
Luccarini, P1
Dallel, R1

Trials

1 trial available for oxidopamine and Epileptiform Neuralgia

ArticleYear
GABAAergic inhibition or dopamine denervation of the A11 hypothalamic nucleus induces trigeminal analgesia.
    Pain, 2015, Volume: 156, Issue:4

    Topics: Animals; Calcitonin Gene-Related Peptide; Denervation; Dopamine; Dorsomedial Hypothalamic Nucleus; F

2015

Other Studies

1 other study available for oxidopamine and Epileptiform Neuralgia

ArticleYear
Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia.
    Brain and behavior, 2014, Volume: 4, Issue:3

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Extracellular Signal-Regulat

2014